Endexx Corporation — Cyborg Score 2/10

Challenged
CBD and hemp-derived wellness products

Strategic Profile

The company serves medical, biotech, and life science industries. Endexx operates as a micro-cap OTC-traded entity with limited market capitalization and profitability, positioning itself in the competitive but growing CBD and plant-based wellness sector with direct-to-consumer and B2B channels.

Cyborg Score Rationale

Endexx is a micro-cap OTC company with extremely limited market cap (~$59K as of January 2025) and minimal profitability despite growing revenue. The company operates in a highly fragmented and competitive CBD market with limited analyst coverage and significant regulatory uncertainty surrounding hemp and cannabis products.

Top Insights

  • Multi-brand portfolio spanning CBD products (CBD Unlimited), pet wellness (PhytoBites), and non-nicotine vaping (HYLA) provides diversification but dilutes focus
  • Revenue grew 228.66% in 2022 to $2.14M but remains highly unprofitable, with 2022 net losses of $4.88M indicating unsustainable burn rate
  • OTC Pink Sheets listing with minimal institutional support and extremely small market capitalization suggests limited liquidity and investment credibility
  • E-commerce and retail distribution model depends on regulatory environment for hemp-derived products, which remains uncertain federally and varies by state

Named Competitors

  • CBD Products — Leading CBD wellness brand with broader distribution
  • Hemp/CBD Products — Large-scale cannabis and hemp retailer with national presence
  • CBD Topicals and Wellness — CBD and hemp-derived wellness products

Recent Developments

  • (February 2025) Filed Q4 2024 financials and announced removal of yield sign, indicating compliance improvements
  • (October 2024) Appointed Doug Williams, CPA, as Fractional CFO through consulting firm
  • (August 2024) HYLA division announced success in launching new product lines and expanding market penetration
  • (April 2024) Reported significant increase in revenue with strategic rebranding initiatives toward HYLA

Open the full interactive Endexx Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →